InChI=1S/C42H69N3O32/c1- 11(51) 43- 21- 14(54) 4- 41(39(65) 66,74- 31(21) 24(58) 16(56) 6- 46) 76- 34- 26(60) 18(8- 48) 70- 37(28(34) 62) 72- 30- 20(10- 50) 69- 36(64) 23(45- 13(3) 53) 33(30) 73- 38- 29(63) 35(27(61) 19(9- 49) 71- 38) 77- 42(40(67) 68) 5- 15(55) 22(44- 12(2) 52) 32(75- 42) 25(59) 17(57) 7- 47/h14- 38,46- 50,54- 64H,4- 10H2,1- 3H3,(H,43,51) (H,44,52) (H,45,53) (H,65,66) (H,67,68) /t14- ,15- ,16+,17+,18+,19+,20+,21+,22+,23+,24+,25+,26- ,27- ,28+,29+,30+,31+,32+,33+,34- ,35- ,36+,37- ,38- ,41- ,42- /m0/s1 |
MJLWBGNNRFKTKY-AAOFEPKHSA-N |
[H] [C@] 1(O[C@@] (C[C@H] (O) [C@H] 1NC(C) =O) (O[C@H] 1[C@@H] (O) [C@@H] (CO) O[C@@H] (O[C@@H] 2[C@@H] (CO) O[C@@H] (O) [C@H] (NC(C) =O) [C@H] 2O[C@@H] 2O[C@H] (CO) [C@H] (O) [C@H] (O[C@@] 3(C[C@H] (O) [C@@H] (NC(C) =O) [C@@] ([H] ) (O3) [C@H] (O) [C@H] (O) CO) C(O) =O) [C@H] 2O) [C@@H] 1O) C(O) =O) [C@H] (O) [C@H] (O) CO |
|
epitope
The biological role played by a material entity when bound by a receptor of the adaptive immune system. Specific site on an antigen to which an antibody binds.
|
|
View more via ChEBI Ontology
Outgoing
|
α- Neup5Ac- (2→3)- β- D- Galp- (1→3)- [α- Neup5Ac- (2→3)- β- D- Galp- (1→4)]- β- D- GlcpNAc
(CHEBI:71594)
has role
epitope
(CHEBI:53000)
α- Neup5Ac- (2→3)- β- D- Galp- (1→3)- [α- Neup5Ac- (2→3)- β- D- Galp- (1→4)]- β- D- GlcpNAc
(CHEBI:71594)
is a
amino pentasaccharide
(CHEBI:59268)
α- Neup5Ac- (2→3)- β- D- Galp- (1→3)- [α- Neup5Ac- (2→3)- β- D- Galp- (1→4)]- β- D- GlcpNAc
(CHEBI:71594)
is a
glucosamine oligosaccharide
(CHEBI:22485)
|
|
5- acetamido- 3,5- dideoxy- D- glycero- α- D- galacto- non- 2- ulopyranonosyl- (2→3)- β- D- galactopyranosyl- (1→3)- [5- acetamido- 3,5- dideoxy- D- glycero- α- D- galacto- non- 2- ulopyranonosyl- (2→3)- β- D- galactopyranosyl- (1→4)]- 2- acetamido- 2- deoxy- β- D- glucopyranose
|
α- Neu5Ac- (2→3)- β- D- Gal- (1→3)- [α- Neu5Ac- (2→3)- β- D- Gal- (1→4)]- β- D- GlcNAc
|
ChEBI
|
β- D- glucopyranose, O- 5- (acetylamino)- 3,5- dideoxy- D- glycero- α- D- galacto- 2- nonulopyranonosyl- (2→3)- O- β- D- galactopyranosyl- (1→3)- O- [O- 5- (acetylamino)- 3,5- dideoxy- D- glycero- α- D- galacto- 2- nonulopyranonosyl- (2→3)- β- D- galactopyranosyl- (1→4)]- 2- (acetylamino)- 2- deoxy-
|
ChEBI
|
N- acetyl- α- neuraminyl- (2→3)- β- D- galactosyl- (1→3)- [N- acetyl- α- neuraminyl- (2→3)- β- D- galactosyl- (1→4)]- N- acetyl- β- D- glucosamine
|
ChEBI
|
Neu5Aca2-3Galb1-4(Neu5Aca2-3Galb1-3)GlcNAcb
|
ChEBI
|
Neu5Acα2-3Galβ1-3(Neu5Acα2-3Galβ1-4)GlcNAcβ
|
ChEBI
|
O- 5- (acetylamino)- 3,5- dideoxy- D- glycero- α- D- galacto- 2- nonulopyranonosyl- (2→3)- O- β- D- galactopyranosyl- (1→3)- O- [O- 5- (acetylamino)- 3,5- dideoxy- D- glycero- α- D- galacto- 2- nonulopyranonosyl- (2→3)- β- D- galactopyranosyl- (1→4)]- 2- (acetylamino)- 2- deoxy- β- D- glucopyranose
|
ChEBI
|
WURCS=2.0/3,5,4/[a2122h- 1b_1- 5_2*NCC/3=O][a2112h- 1b_1- 5][Aad21122h- 2a_2- 6_5*NCC/3=O]/1- 2- 3- 2- 3/a3- b1_a4- d1_b3- c2_d3- e2
|
GlyTouCan
|
19443021
|
PubMed citation
|
Europe PMC
|
25568069
|
PubMed citation
|
Europe PMC
|
31537530
|
PubMed citation
|
Europe PMC
|
|